Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare the safety and effectiveness (how well the
medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any
medication) taken daily in relieving nighttime heartburn and problems sleeping in patients
with gastroesophageal reflux disease (GERD).